Twinbeech Capital LP Immunity Bio, Inc. Transaction History

Twinbeech Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$9.17 - $14.24 $768,125 - $1.19 Million	-83,765 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $751,147 - $1.25 Million	56,014 Added 201.84%	83,765 $1.2 Million
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $356,045 - $1.17 Million	27,751 New	27,751 $659,000

205

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.13B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.